Objective To explore radiotoxicity of 125I labeled nerve growth factor (125I-NGF) in U251. Methods Absorbance values of U251 treated with 18.5, 37.0, 74.0, 148.0, 296.0, 592.0,1184. 0, 1480. 0, 1850. 0, 2590. 0, 3330. 0, 3700. 0 kBq/ml 125I-NGF were detected by MTT assay. The corresponding minimum concentration of 125I-NGF tending to the minimum absorbance value was selected as minimum effective concentration, and was adopted in follow-up experiments. Plate colony-forming assay was adopted to compare the proliferation ability of cells treated with complete culture medium, 592 kBq/ml Na125I, 1 mg/L NGF and 592 kBq/ml 125I-NGF. Distribution of silver particles within the cells was observed by autoradiography to respond the existence of 125 I-NGF inside the cells. DNA damage was evaluated by comet assay and micronuclei forming assay. The proportion of cells in G0/G1 or S p hase was determined by flow cytometry. Results Minimal effective concentration of 125I-NGF was 592. 0 kBq/ml. Under thisconcentration, 125I-NGF could be transported to the nuclei of U251 and caused DNA damage. Being treated with 125I-NGF, U251 clone forming rate was (0. 02 ± 0. 01 ), compared to control group (0. 33 ± 0. 02),the proliferation of U251 was inhibited remarkably (P <0. 01 ). The proportion of cells in S phase ( 10. 69± 0. 02) was decreased, but that in Go/G1 phase ( 75. 10 ± 0. 22 ) increased remarkably ( P < 0. 01 ).Conclusion After being iodinated with 125I,125I-NGF can be transported to nuclei and causes DNA damage in U251. 125I-NGF has specific lethal effect on U251 cells in S phase. Key words: Radionuclide; Targeted therapy; Glioma
Read full abstract